APP and Alzheimer disease: The APPNL-G-F mouse contains an endogenous promoter-driven single knock-in of human APP incorporating three familial AD-associated mutations that together promote toxicity and plaque formation by increasing Aβ production and aggregation; it is a robust model for studying plaques and glial responses to plaques but lacks other components of AD pathology.